Mutational profiles and treatment resistance in metastatic TNBC

Tempus Lens analysis identifies genomic markers of chemotherapy resistance in TNBC patients

INDICATION
Breast
BIOMARKER
PIK3CA

 

Barplot comparing frequency of mutated genes with the most significant difference in prevalence of pathogenic somatic mutations between pre-treatment, primary resistance, and acquired resistance patients after 1L of treatment. Fisher p<0.1 across groups.

 

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Three abstract data distributions displayed as shapes made of small, colored squares.

Sacituzumab govitecan and tumor microenvironment shifts in metastatic triple-negative breast cancer

2026-07-01
CXCL/SPP1 (CS)
Breast
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
A blue grid with dark blue squares forming a descending diagonal path, possibly a heatmap.

Optimizing therapy sequencing for HR+ HER2- metastatic breast cancer

2026-05-26
Breast
HER2
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Unable to determine image content.

ESR1 mutations and copy number loss in breast cancer

2026-05-26
Breast
ESR1